It's all changing at Zeiss

Article

Recent acquisitions, division restructuring, and management changes prove that Carl Zeiss Meditec is very much committed to change. Ophthalmology Times Europe spoke with new CEO, Dr Michael Kaschke, about the challenges that he faces in an ever-evolving market.

Recent acquisitions, division restructuring, and management changes prove that Carl Zeiss Meditec is very much committed to change. Ophthalmology Times Europe spoke with new CEO, Dr Michael Kaschke, about the challenges that he faces in an ever-evolving market.

Connectivity of devices is a big focus for Zeiss. According to Dr Kaschke, doctors want simplicity and, in order to give them this, Zeiss must commit to providing seamless workflow solutions.

As part of this enhanced product offering, one cannot forget last year’s acquisition of Acri.Tec, which well and truly catapulted the company into the IOL market.

Although it believes it now has the best lenses on the market carrying its name, new lens launches continue to be announced by Zeiss. In fact, three new lenses will soon be added to its portfolio. Specifically, the three yellow IOLs: Acri.Lyc 44YLC, Acri.Smart 46YLC, and Acri.Lyc 47YLC, will be available in Europe by the end of the year.

To read the full interview, please click here.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.